|
BCLAF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.176480E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.562700E-04 |
| Normal-vs-Stage2 |
1.151190E-01 |
| Normal-vs-Stage3 |
7.974400E-02 |
| Normal-vs-Stage4 |
2.563000E-01 |
| Stage1-vs-Stage2 |
6.940800E-01 |
| Stage1-vs-Stage3 |
5.140200E-01 |
| Stage1-vs-Stage4 |
7.106800E-01 |
| Stage2-vs-Stage3 |
8.902000E-01 |
| Stage2-vs-Stage4 |
9.516000E-01 |
| Stage3-vs-Stage4 |
9.636200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.617480E-03 |
| Normal-vs-AfricanAmerican |
6.499100E-03 |
| Normal-vs-Asian |
5.85100000000116E-05 |
| Caucasian-vs-AfricanAmerican |
9.713600E-01 |
| Caucasian-vs-Asian |
2.029700E-02 |
| AfricanAmerican-vs-Asian |
3.812200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.024810E-04 |
| Normal-vs-Female |
3.950000E-01 |
| Male-vs-Female |
7.803100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.357200E-03 |
| Normal-vs-Extreme_Weight |
1.441160E-04 |
| Normal-vs-Obese |
6.521700E-02 |
| Normal-vs-Extreme_Obese |
2.217200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.964200E-01 |
| Normal_Weight-vs-Obese |
3.135000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.682800E-01 |
| Extreme_Weight-vs-Obese |
6.258400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.368800E-01 |
| Obese-vs-Extreme_Obese |
1.556600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.795820E-01 |
| Normal-vs-Age(41-60Yrs) |
7.609600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.24209999999992E-05 |
| Normal-vs-Age(81-100Yrs) |
6.01849999999349E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.723800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.077800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.520490E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.118270E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.135900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.319700E-03 |
| Normal-VS-Type2 PRCC |
3.89470000000669E-05 |
| Normal-VS-KIRP CIMP |
2.701800E-01 |
| Normal-VS-Unclassified PRCC |
2.211200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.976500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.366400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.495000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.753220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.443700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.858000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17639999999797E-05 |
| Normal-vs-N1 |
6.797000E-01 |
| Normal-vs-N2 |
5.242100E-03 |
| N0-vs-N1 |
4.437300E-03 |
| N0-vs-N2 |
5.044800E-01 |
| N1-vs-N2 |
1.093620E-01 |
|
|
